61 results
424B5
YTEN
Yield10 Bioscience Inc
2 Feb 21
Prospectus supplement for primary offering
4:36pm
to complete the regulatory process for or commercialize such products.
If we lose key personnel or are unable to attract and retain necessary talent … on our business and operations.
If we lose key personnel or are unable to attract and retain necessary talent, we may be unable to develop
424B5
YTEN
Yield10 Bioscience Inc
29 Jan 21
Prospectus supplement for primary offering
4:48pm
key personnel or are unable to attract and retain necessary talent, we may be unable to develop or commercialize our products under development … talent, we may be unable to develop or commercialize our products under development.
We are highly dependent on our key technical and scientific
424B4
0n2e4
19 Oct 20
Prospectus supplement with pricing info
4:51pm
424B5
2j7xe1hb nm99hm80g3
25 Aug 20
Prospectus supplement for primary offering
4:08pm
424B5
uefdya
21 Aug 20
Prospectus supplement for primary offering
5:22pm
424B4
0vhou 2rmm
3 Apr 20
Prospectus supplement with pricing info
10:36am
424B4
uo6dy538fqcxe18s
18 Nov 19
Prospectus supplement with pricing info
12:00am
424B5
wdyc4isy5ny8
18 Mar 19
Prospectus supplement for primary offering
12:00am